MOREPEN LABORATORIES
|
MOREPEN LABORATORIES Last 5 Year Balance Sheet History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹102 Cr | ₹102 Cr | ₹96 Cr | ₹90 Cr | ₹90 Cr |
Equity - Authorised | ₹200 Cr | ₹200 Cr | ₹130 Cr | ₹130 Cr | ₹90 Cr |
Equity - Issued | ₹102 Cr | ₹102 Cr | ₹96 Cr | ₹90 Cr | ₹90 Cr |
Equity Paid Up | ₹102 Cr | ₹102 Cr | ₹96 Cr | ₹90 Cr | ₹90 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 |
Share Warrants & Outstandings | - | - | ₹26 Cr | ₹44 Cr | - |
Total Reserves | ₹745 Cr | ₹651 Cr | ₹457 Cr | ₹291 Cr | ₹194 Cr |
Securities Premium | ₹370 Cr | ₹370 Cr | ₹232 Cr | ₹167 Cr | ₹167 Cr |
Capital Reserves | ₹21 Cr | ₹21 Cr | ₹2.70 Cr | ₹2.70 Cr | ₹2.70 Cr |
Profit & Loss Account Balance | ₹286 Cr | ₹190 Cr | ₹151 Cr | ₹55 Cr | ₹-42 Cr |
General Reserves | - | - | - | - | - |
Other Reserves | ₹68 Cr | ₹69 Cr | ₹71 Cr | ₹66 Cr | ₹66 Cr |
Reserve excluding Revaluation Reserve | ₹745 Cr | ₹651 Cr | ₹457 Cr | ₹291 Cr | ₹194 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹847 Cr | ₹753 Cr | ₹579 Cr | ₹425 Cr | ₹284 Cr |
Minority Interest | - | ₹-0.46 Cr | ₹-0.46 Cr | ₹-0.46 Cr | ₹-0.46 Cr |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹3.36 Cr | ₹0.93 Cr | ₹1.32 Cr | ₹0.83 Cr | ₹0.93 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹3.36 Cr | ₹0.93 Cr | ₹1.32 Cr | ₹0.83 Cr | ₹0.93 Cr |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹2.25 Cr | ₹2.69 Cr | ₹2.48 Cr | - | - |
Deferred Tax Assets | ₹10 Cr | ₹9.57 Cr | ₹9.18 Cr | - | - |
Deferred Tax Liability | ₹13 Cr | ₹12 Cr | ₹12 Cr | - | - |
Other Long Term Liabilities | ₹4.50 Cr | ₹3.52 Cr | ₹3.45 Cr | ₹3.83 Cr | ₹3.68 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹34 Cr | ₹30 Cr | ₹28 Cr | ₹25 Cr | ₹24 Cr |
Total Non-Current Liabilities | ₹44 Cr | ₹37 Cr | ₹35 Cr | ₹30 Cr | ₹28 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹295 Cr | ₹227 Cr | ₹258 Cr | ₹209 Cr | ₹172 Cr |
Sundry Creditors | ₹295 Cr | ₹227 Cr | ₹258 Cr | ₹209 Cr | ₹172 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹59 Cr | ₹55 Cr | ₹170 Cr | ₹174 Cr | ₹165 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹1.54 Cr | ₹1.46 Cr | ₹5.63 Cr | ₹1.85 Cr | ₹6.21 Cr |
Interest Accrued But Not Due | - | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹57 Cr | ₹53 Cr | ₹164 Cr | ₹173 Cr | ₹159 Cr |
Short Term Borrowings | ₹23 Cr | ₹23 Cr | ₹16 Cr | ₹15 Cr | ₹11 Cr |
Secured ST Loans repayable on Demands | ₹23 Cr | ₹23 Cr | ₹16 Cr | ₹15 Cr | ₹11 Cr |
Working Capital Loans- Sec | ₹23 Cr | ₹23 Cr | ₹16 Cr | ₹15 Cr | ₹11 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-23 Cr | ₹-23 Cr | ₹-16 Cr | ₹-15 Cr | ₹-11 Cr |
Short Term Provisions | ₹25 Cr | ₹16 Cr | ₹12 Cr | ₹5.25 Cr | ₹2.72 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹13 Cr | ₹6.50 Cr | ₹5.09 Cr | ₹1.49 Cr | ₹0.30 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹12 Cr | ₹9.74 Cr | ₹7.15 Cr | ₹3.77 Cr | ₹2.42 Cr |
Total Current Liabilities | ₹402 Cr | ₹321 Cr | ₹456 Cr | ₹404 Cr | ₹351 Cr |
Total Liabilities | ₹1,293 Cr | ₹1,110 Cr | ₹1,070 Cr | ₹858 Cr | ₹663 Cr |
ASSETS | |||||
Gross Block | ₹621 Cr | ₹656 Cr | ₹613 Cr | ₹628 Cr | ₹753 Cr |
Less: Accumulated Depreciation | ₹313 Cr | ₹389 Cr | ₹361 Cr | ₹404 Cr | ₹536 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹307 Cr | ₹267 Cr | ₹252 Cr | ₹225 Cr | ₹216 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹24 Cr | ₹17 Cr | ₹14 Cr | ₹1.96 Cr | - |
Non Current Investments | ₹1.30 Cr | - | - | ₹1.09 Cr | ₹1.09 Cr |
Long Term Investment | ₹1.30 Cr | - | - | ₹1.09 Cr | ₹1.09 Cr |
Quoted | ₹1.30 Cr | - | - | ₹1.09 Cr | ₹1.09 Cr |
Unquoted | - | - | - | - | - |
Long Term Loans & Advances | ₹71 Cr | ₹70 Cr | ₹70 Cr | ₹104 Cr | ₹74 Cr |
Other Non Current Assets | ₹0.24 Cr | ₹0.28 Cr | ₹0.28 Cr | ₹0.27 Cr | ₹0.28 Cr |
Total Non-Current Assets | ₹404 Cr | ₹354 Cr | ₹336 Cr | ₹331 Cr | ₹291 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹249 Cr | ₹229 Cr | ₹276 Cr | ₹175 Cr | ₹138 Cr |
Raw Materials | ₹145 Cr | ₹127 Cr | ₹157 Cr | ₹67 Cr | ₹72 Cr |
Work-in Progress | ₹37 Cr | ₹39 Cr | ₹36 Cr | ₹44 Cr | ₹20 Cr |
Finished Goods | ₹31 Cr | ₹35 Cr | ₹37 Cr | ₹37 Cr | ₹28 Cr |
Packing Materials | - | - | - | - | - |
Stores  and Spare | ₹3.67 Cr | ₹4.50 Cr | ₹3.49 Cr | ₹2.61 Cr | ₹2.09 Cr |
Other Inventory | ₹32 Cr | ₹24 Cr | ₹42 Cr | ₹26 Cr | ₹17 Cr |
Sundry Debtors | ₹325 Cr | ₹263 Cr | ₹251 Cr | ₹182 Cr | ₹138 Cr |
Debtors more than Six months | ₹15 Cr | ₹7.69 Cr | ₹5.81 Cr | ₹4.81 Cr | - |
Debtors Others | ₹313 Cr | ₹258 Cr | ₹251 Cr | ₹182 Cr | ₹139 Cr |
Cash and Bank | ₹52 Cr | ₹56 Cr | ₹46 Cr | ₹68 Cr | ₹39 Cr |
Cash in hand | ₹0.17 Cr | ₹0.25 Cr | ₹0.10 Cr | ₹0.12 Cr | ₹0.21 Cr |
Balances at Bank | ₹52 Cr | ₹56 Cr | ₹46 Cr | ₹68 Cr | ₹39 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹16 Cr | ₹7.15 Cr | ₹5.29 Cr | ₹10 Cr | ₹5.98 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | ₹1.56 Cr | ₹0.98 Cr | ₹0.58 Cr | ₹0.58 Cr | ₹0.56 Cr |
Prepaid Expenses | ₹10 Cr | ₹4.55 Cr | ₹2.13 Cr | ₹1.18 Cr | ₹1.40 Cr |
Other current_assets | ₹4.80 Cr | ₹1.62 Cr | ₹2.58 Cr | ₹8.25 Cr | ₹4.01 Cr |
Short Term Loans and Advances | ₹247 Cr | ₹201 Cr | ₹157 Cr | ₹92 Cr | ₹51 Cr |
Advances recoverable in cash or in kind | ₹216 Cr | ₹166 Cr | ₹118 Cr | ₹69 Cr | ₹40 Cr |
Advance income tax and TDS | - | - | ₹0.53 Cr | ₹0.01 Cr | ₹0.01 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹31 Cr | ₹34 Cr | ₹38 Cr | ₹23 Cr | ₹11 Cr |
Total Current Assets | ₹889 Cr | ₹756 Cr | ₹734 Cr | ₹527 Cr | ₹372 Cr |
Net Current Assets (Including Current Investments) | ₹487 Cr | ₹435 Cr | ₹278 Cr | ₹123 Cr | ₹21 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹1,293 Cr | ₹1,110 Cr | ₹1,070 Cr | ₹858 Cr | ₹663 Cr |
Contingent Liabilities | ₹9.76 Cr | ₹6.66 Cr | ₹2.64 Cr | ₹0.93 Cr | ₹1.27 Cr |
Total Debt | ₹29 Cr | ₹25 Cr | ₹19 Cr | ₹17 Cr | ₹13 Cr |
Book Value | - | 14.73 | 11.56 | 8.47 | 6.32 |
Adjusted Book Value | 16.58 | 14.73 | 11.56 | 8.47 | 6.32 |
Compare Balance Sheet of peers of MOREPEN LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MOREPEN LABORATORIES | ₹2,713.1 Cr | 4.3% | 6.7% | 17.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹411,306.0 Cr | -2.5% | 7.6% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹150,343.0 Cr | -3% | 3.4% | 61.5% | Stock Analytics | |
CIPLA | ₹117,323.0 Cr | -1.6% | 3% | -3.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹108,619.0 Cr | -0.3% | 9% | 22.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹95,941.5 Cr | -1.2% | 2.9% | -6.4% | Stock Analytics |
MOREPEN LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MOREPEN LABORATORIES | 4.3% |
6.7% |
17.4% |
SENSEX | -1.8% |
2.7% |
5% |
You may also like the below Video Courses